Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Sep;14(9):771-4.

Clinical trial with bromelain in third molar exodontia

Affiliations
  • PMID: 21061836
Multicenter Study

Clinical trial with bromelain in third molar exodontia

F Inchingolo et al. Eur Rev Med Pharmacol Sci. 2010 Sep.

Abstract

Background and objective: Bromelain is a proteolytic enzyme, particularly effective in the treatment of soft tissue inflammations and traumas, in localized inflammations, especially in presence of hydropsy and also in postoperative tissue reactions. The aim of the present study is to assess the efficacy of bromelain in controlling the edema and its related pain in the inflamed area after upper third molar exodontia.

Materials and methods: The effectiveness of our protocol was evaluated by a clinical assessment of the profile of the hemiface corresponding to the treated area: indeed, the linear values of the trago-pogonion distances were measured. Algogens were determined by VAS (Visual Analogue Scale) (Figure 1) with integers ranging from 1 (no pain) to 8 (maximum pain) up to a maximum of 10 (paroxysmal and unbearable pain).

Results and conclusions: The obtained results clearly demonstrate the effectiveness of bromelain in treating postoperative edema after third molar surgery.

PubMed Disclaimer

Publication types

LinkOut - more resources